Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
127069272	12706927	2	F		20160908	20160901	20160912	EXP		CN-ROCHE-1823099	ROCHE	ZHANG R, LU Z-H, WANG F-L, WAN D, GAO Y-H, ZENG Z-F, DING P-R, WU X-J, LI L-R AND LIN J-Z. THE SAFETY OF FOUR CYCLES OF CAPEOX COMBINED WITH RADIOTHERAPY VS. CAPECITABINE COMBINE WITH RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER: MID-TERM ANALYSIS OF NCT02031939 (ABSTRACT NUMBER: E14040). JOURNAL OF CLINICAL ONCOLOGY 2016 MAY;34 (SUP15):-.	0.00				Y	0.00000		20160912		OT	CN	CN

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	LOT NUM	EXP DT	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
127069272	12706927	1	PS	CAPECITABINE.	CAPECITABINE	1	Unknown				U				20896			TABLET
127069272	12706927	2	SS	OXALIPLATIN.	OXALIPLATIN	1	Unknown				U				0

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
127069272	12706927	1	Rectal cancer
127069272	12706927	2	Rectal cancer

Outcome of event

Event ID	CASEID	OUTC COD
127069272	12706927	OT

Reactions reported

Event ID	CASEID	PT
127069272	12706927	Leukopenia
127069272	12706927	Renal disorder
127069272	12706927	Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

no results found

no results found